Nalmefene: Safety and Kinetics After Single and Multiple Oral Doses of a New Opioid Antagonist-Reference-Cited by-同舟云学术

Nalmefene: Safety and Kinetics After Single and Multiple Oral Doses of a New Opioid Antagonist

Published:1987-03 Issue:3 Volume:27 Page:233-239
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Dixon Ross,Gentile Joseph,Hsu Hon-Bin,Hsiao Jane,Howes John,Garg Dyal,Weidler Donald

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1552-4604.1987.tb02191.x/fullpdf

Reference11 articles.

1. Binding of a new opiate antagonist, nalmefene, to rat brain membranes;Michel;Methods Find Exp Clin Pharmacol,1985

2. Narcotic natagonists: 4. Carbon-6 derivatives of N-substituted noroxymorphones as narcotic antagonists;Hahn;J Med Chem,1975

3. Nalmefene: Intravenous safety and kinetics of a new opioid antagonist;Dixon;Clin Pharmacol Ther,1986

4. Nalmefene: Radioimmunoassay for a new opioid antagosinst;Dixon;J Pharm Sci,1984

5. Nalmefene: Quantitation of a new narcotic antagonist in human plasma using HPLC with electrochemical detection;Hsiao;Res Comm Chem Pathol Pharmacol,1983

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reversal of subtype-selectivity and function by the introduction of a para-benzamidyl substituent to N-cyclopropylmethyl nornepenthone;European Journal of Medicinal Chemistry;2023-10

2. Pharmacokinetic Properties of an FDA‐approved Intranasal Nalmefene Formulation for the Treatment of Opioid Overdose;Clinical Pharmacology in Drug Development;2023-07-27

3. Treatment of opioid overdose: current approaches and recent advances;Psychopharmacology;2022-04-07

4. Pharmacologic and Clinical Considerations of Nalmefene, a Long Duration Opioid Antagonist, in Opioid Overdose;Psychiatry International;2021-10-14

5. Nalmefene, a mu opioid receptor antagonist/kappa opioid receptor partial agonist, potentiates cocaine motivation but not intake with extended access self-administration in adult male mice;Neuropharmacology;2021-07